|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.700 GBX | +2.17% |
|
+11.90% | +17.50% |
| 15/04 | Windar hails 'strongest ever first quarter' | AN |
| 15/04 | Poolbeg Pharma Secures Topical Trial Authorization for POLB 001 Therapy in UK | MT |
Evolution of the Average Target: Poolbeg Pharma PLC
Evolution of the Target Price: Poolbeg Pharma PLC
Changes in Analyst Recommendations: Poolbeg Pharma PLC
087745db7ca68b3f702cd500.V4qdB1Mwe1QvouqYKpy-Me6pJirIK7SB5aME4I0hUhg.Zb_QX2UHNjEZ26HHa_bRSbabfmulXMbuke1PkcoMAFQYs65QNV4yM33QhQ~162d2949fec504dffc449781fcb10c69
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +313.04% | |||
| +18.67% | |||||
| +26.02% | |||||
| +44.71% | |||||
| +33.77% | |||||
| +24.57% | |||||
| +21.46% | |||||
| +18.18% | |||||
| +48.1% | |||||
| +2.74% | |||||
| Average | +55.13% | |||||
| Weighted average by Cap. | +26.73% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0460GBP
Average target price
0.1900GBP
Spread / Average Target
+313.04%
High Price Target
0.1900GBP
Spread / Highest target
+313.04%
Low Price Target
0.1900GBP
Spread / Lowest Target
+313.04%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0460GBP
Average target price
0.1900GBP
Spread / Average Target
+313.04%
Annual profits - Rate of surprise
- Stock Market
- Equities
- POLB Stock
- Consensus Poolbeg Pharma PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition